Company,Total_Links,Text_Length_Characters,Extraction_Date,Status
DRREDDY,4,869,2025-08-21 21:28:44,Completed

EXTRACTED_LINKS
Link_Number,URL
Link_1,https://www.drreddys.com/cms/cms/sites/default/files/2025-05/Earnings%20Release_Q4FY25_090525_Final.pdf
Link_2,"https://ehealth.eletsonline.com/2025/04/dr-reddys-expands-partnership-with-sanofi-to-launch-rsv-drug-beyfortus-in-india/#:~:text=Dr.,Beyfortus%20in%20India%20%2D%20Elets%20eHealth"
Link_3,"https://thehealthmaster.com/2025/05/19/usfda-inspection-at-reddys-api-plant/#:~:text=In%20May%202025%2C%20the%20United,FDA%20check%20of%20its%20requirements."
Link_4,https://nsearchives.nseindia.com/corporate/DRREDDY_09052025180415_SE_intimation_Reg30_09052025.pdf

EXTRACTED_TEXT_CONTENT
Content_Type,Content
Complete_Text,"May 9, 2025: Dr. Reddy's Laboratories announced its Q4 and full year FY25 financial results.

Dr. Reddy's Laboratories and Sanofi Healthcare India Private Limited expanded their partnership to launch Beyfortus® (nirsevimab) in India. This drug is for preventing Respiratory Syncytial Virus in infants.

May 9, 2025: Dr. Reddy's Laboratories incorporated a new wholly-owned subsidiary in Vietnam, named “Dr. Reddy's Laboratories (Vietnam) Company Limited”.

May 2025: A USFDA inspection was conducted at Dr. Reddy's Laboratories Middleburgh, New York, manufacturing site.

DRREDDY stock information on May 1, 2025 is not available. However, news and updates for DRREDDY company from around that period are:

Note : There's a discrepancy in the publication dates of the search results, with some information dated in April but appearing in results related to May 1, 2025."
